1 Neuroscience Research, AbbVie, 6706 Ludwigshafen, Germany. Present address: Partnership for Assessment and Accreditation of Scientific Practice, Am Aukopf 14/1, D-69118 Heidelberg, Germany and Institute of Pharmacology, Pavlov Medical University, 197022 St Petersburg, Russia.
2 Janssen Research and Development, B-2340 Beerse, Belgium.
3 Global Policy and International Public Affairs, Pfizer, New York, 10017 New York, USA.
4 National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland 20892, USA.
5 Non-Clinical Research and Development, Alkermes, Waltham, Massachusetts 02451, USA.
6 Institut de Recherche Servier, 78290 Croissy sur Seine, France.
7 Neuroscience Research, H. Lundbeck A/S, Copenhagen, 2500 Valby, Denmark.
8 Discovery Chemistry &DMPK; Lundbeck Research USA, Paramus, New Jersey 07652, USA. Present address: Concert Pharmaceuticals, Inc., 99 Hayden Avenue, Lexington, Massachusetts 02421, USA.
9 Neuroscience Discovery Research, Lilly Research Labs, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
10 Pierre Fabre Research Institute, 81106 Castres, France. Present address: BIAL-Portela &Ca S.A., Avenida da Siderurgia Nacional, 4745-457 São Mamede do Coronado, Portugal.
11 Neuroscience and Pain Research Unit, Pfizer, Cambridge, Massachusetts 02139, USA.
12 Boehringer Ingelheim Pharma, 55218 Ingelheim am Rhein, Germany.
13 University of California San Diego, La Jolla, California 92093, USA.
14 Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, CH-4070 Basel, Switzerland.
15 Edinburgh University, Old College, South Bridge, Edinburgh EH8 9YL, UK.